Central Sensitization in Chronic Low Back Pain and Comorbid Fibromyalgia
Patients with chronic low back pain and comorbid fibromyalgia may have central sensitization and psychosocial symptoms.
Patients with chronic low back pain and comorbid fibromyalgia may have central sensitization and psychosocial symptoms.
The FDA has granted Fast Track designation for IDCT (DiscGenics, Inc.), an investigational cell therapy for the reduction in pain and disability associated with degenerative disc disease (DDD).
A steroid injection into the atlantoaxial joint (AAJ) was found to decrease cervical neck pain and improve neck mobility and rate of recovery rate in patients with acutely inflamed AAJ related to rheumatoid arthritis.
Self-administered acupressure may be efficacious for reducing pain and fatigue in patients with chronic low back pain.
Frequent persistent back pain is associated with increased mortality in older women.
Well-being was found to be associated with psychosocial resources and subjective evaluations to a greater extent than with objective measures in patients with chronic back pain.
Dorsal root ganglion neurostimulation therapy may reduce pain and disability in patients with chronic lower extremity and back pain.
Inflammatory back pain often resolves, while in 30 percent of patients it progresses to spondyloarthritis within 10 years.
For patients with lumbosacral disk herniation being considered for epidural steroid injection (ESI) to treat back and radicular pain, transforaminal ESI may be superior to caudal ESI in terms of clinical outcomes.
An elastic net algorithm was used to create a predictive model of postoperative pain in the first 24 hours after surgery using a randomly selected training cohort.